Major depressive disorder Trials in Chicago, United States
Conditions / Major depressive disorder / Chicago, United States
Clinical trials for Major depressive disorder investigate a range of treatment strategies and patient populations.
97 total trials for this combination
Showing top 10 of 97 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01436175 | SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study | TERMINATED | PHASE3 |
| NCT04855747 | A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD) | TERMINATED | PHASE3 |
| NCT01085812 | Relapse-Prevention Study With Levomilnacipran ER (F2695 SR) in Patients With Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT04039022 | Open-Label Safety Study of AXS-05 in Subjects With Depression | COMPLETED | PHASE3 |
| NCT03869736 | Nitrous Oxide for the Treatment of Major Depressive Disorder | COMPLETED | PHASE2 |
| NCT04019704 | A Trial of AXS-05 in Patients With Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT01152554 | A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT00006286 | Treatment for Adolescents With Depression Study (TADS) | COMPLETED | PHASE3 |
| NCT07017478 | Mood Effects of Serotonin Agonists: Depression | RECRUITING | EARLY_PHASE1 |
| NCT01157078 | A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder (MDD) | COMPLETED | PHASE3 |